167 related articles for article (PubMed ID: 30680790)
21. The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls.
McMeniman EK; Duffy DL; Jagirdar K; Lee KJ; Peach E; McInerney-Leo AM; De'Ambrosis B; Rayner JE; Smithers BM; Soyer HP; Sturm RA
Br J Dermatol; 2020 Aug; 183(2):357-366. PubMed ID: 31794051
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas.
Strazzulla LC; Li X; Zhu K; Okhovat JP; Lee SJ; Kim CC
J Am Acad Dermatol; 2019 May; 80(5):1292-1298. PubMed ID: 30654075
[TBL] [Abstract][Full Text] [Related]
23. Nodular melanoma is less likely than superficial spreading melanoma to be histologically associated with a naevus.
Pan Y; Adler NR; Wolfe R; McLean CA; Kelly JW
Med J Aust; 2017 Oct; 207(8):333-338. PubMed ID: 29020904
[TBL] [Abstract][Full Text] [Related]
24. Hyporeflective pagetoid cells: a new clue for amelanotic melanoma diagnosis by reflectance confocal microscopy.
Losi A; Longo C; Cesinaro AM; Benati E; Witkowski A; Guitera P; Pellacani G
Br J Dermatol; 2014 Jul; 171(1):48-54. PubMed ID: 24329036
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma.
Kvaskoff M; Whiteman DC; Zhao ZZ; Montgomery GW; Martin NG; Hayward NK; Duffy DL
Twin Res Hum Genet; 2011 Oct; 14(5):422-32. PubMed ID: 21962134
[TBL] [Abstract][Full Text] [Related]
26. A red scaly patch diagnosed as hypomelanotic melanoma.
Aung T; Rosendahl CO; Peng Sung Foong D
N Z Med J; 2022 Jul; 135(1557):88-92. PubMed ID: 35772116
[TBL] [Abstract][Full Text] [Related]
27. Dermoscopic evaluation of amelanotic and hypomelanotic melanoma.
Menzies SW; Kreusch J; Byth K; Pizzichetta MA; Marghoob A; Braun R; Malvehy J; Puig S; Argenziano G; Zalaudek I; Rabinovitz HS; Oliviero M; Cabo H; Ahlgrimm-Siess V; Avramidis M; Guitera P; Soyer HP; Ghigliotti G; Tanaka M; Perusquia AM; Pagnanelli G; Bono R; Thomas L; Pellacani G; Langford D; Piccolo D; Terstappen K; Stanganelli I; Llambrich A; Johr R
Arch Dermatol; 2008 Sep; 144(9):1120-7. PubMed ID: 18794455
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological characteristics and prognosis of amelanotic acral melanoma: A comparative study with pigmented acral melanoma.
Gong HZ; Zheng HY; Li J
Australas J Dermatol; 2020 Nov; 61(4):358-361. PubMed ID: 32424819
[TBL] [Abstract][Full Text] [Related]
29. Somatic mutations in GNAQ in amelanotic/hypomelanotic blue nevi.
Emley A; Nguyen LP; Yang S; Mahalingam M
Hum Pathol; 2011 Jan; 42(1):136-40. PubMed ID: 21056896
[TBL] [Abstract][Full Text] [Related]
30. Amelanotic melanoma: the great masquerader.
Koch SE; Lange JR
J Am Acad Dermatol; 2000 May; 42(5 Pt 1):731-4. PubMed ID: 10775846
[TBL] [Abstract][Full Text] [Related]
31. Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.
Thomas NE; Edmiston SN; Kanetsky PA; Busam KJ; Kricker A; Armstrong BK; Cust AE; Anton-Culver H; Gruber SB; Luo L; Orlow I; Reiner AS; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Dwyer T; Parrish EA; Hao H; Gibbs DC; Frank JS; Ollila DW; Begg CB; Berwick M; Conway K;
J Invest Dermatol; 2017 Dec; 137(12):2588-2598. PubMed ID: 28842324
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms.
Avilés JA; Lázaro P; Fernández LP; Benítez J; Ibarrola-Villava M; Ribas G
Actas Dermosifiliogr; 2012 Jan; 103(1):44-50. PubMed ID: 22464597
[TBL] [Abstract][Full Text] [Related]
33. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
34. Matched analysis of the prognosis of amelanotic and pigmented melanoma in head and neck.
Guo W; Yin G; Liu H; Duan H; Huang Z; Chen X
Acta Otolaryngol; 2020 Sep; 140(9):785-788. PubMed ID: 32449432
[No Abstract] [Full Text] [Related]
35. Characterization of patients at high risk of melanoma in Austria.
Müller C; Wendt J; Rauscher S; Burgstaller-Muehlbacher S; Sunder-Plassmann R; Scheurecker C; Richtig E; Fae I; Fischer G; Pehamberger H; Okamoto I
Br J Dermatol; 2016 Jun; 174(6):1308-17. PubMed ID: 26800492
[TBL] [Abstract][Full Text] [Related]
36. Pigmentation-related genes and their implication in malignant melanoma susceptibility.
Fernandez LP; Milne RL; Pita G; Floristan U; Sendagorta E; Feito M; Avilés JA; Martin-Gonzalez M; Lázaro P; Benítez J; Ribas G
Exp Dermatol; 2009 Jul; 18(7):634-42. PubMed ID: 19320733
[TBL] [Abstract][Full Text] [Related]
37. Amelanotic choroidal nevus and melanoma: cytology, tumor size, and pigmentation as prognostic indicators.
Lee DS; Anderson SF; Perez EM; Townsend JC
Optom Vis Sci; 2001 Jul; 78(7):483-91. PubMed ID: 11503936
[TBL] [Abstract][Full Text] [Related]
38. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
[TBL] [Abstract][Full Text] [Related]
39. Dermoscopic diagnosis of amelanotic/hypomelanotic melanoma.
Pizzichetta MA; Kittler H; Stanganelli I; Ghigliotti G; Corradin MT; Rubegni P; Cavicchini S; De Giorgi V; Bono R; Alaibac M; Astorino S; Ayala F; Quaglino P; Pellacani G; Argenziano G; Guardoli D; Specchio F; Serraino D; Talamini R;
Br J Dermatol; 2017 Aug; 177(2):538-540. PubMed ID: 27681347
[No Abstract] [Full Text] [Related]
40. Progressive appearance of pigmentation in amelanotic melanoma lesions.
Cohen-Solal KA; Crespo-Carbone SM; Namkoong J; Mackason KR; Roberts KG; Reuhl KR; Chen S
Pigment Cell Res; 2002 Aug; 15(4):282-9. PubMed ID: 12100494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
